BioMarin Pharmaceuticals BMRN Total debt

Total debt at other companies

Sarepta Therapeutics, Inc.SRPT

$198.23M-7.6%

PTC TherapeuticsPTCT

$395.09M+0.1%

Zevra Therapeutics, Inc.ZVRA

$1.5M-97.6%

Agios PharmaceuticalsAGIO

$31.17M-36.1%

RegenxbioRGNX

$68.95M-11.3%

BridgeBio PharmaBBIO

$3.26B+32,101%

FAQ

What is BioMarin Pharmaceuticals's total debt?

BioMarin Pharmaceuticals (BMRN) reported total debt of $4.19B in Q2 2026.

How has BioMarin Pharmaceuticals's total debt changed year-over-year?

BioMarin Pharmaceuticals's total debt increased by 597.7% year-over-year, from $600M to $4.19B.

What is the long-term trend for BioMarin Pharmaceuticals's total debt?

Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's total debt has grown at a 62.8% compound annual growth rate (CAGR), from $56.24M to $642.87M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.